Research Article | | Peer-Reviewed

Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana

Received: 8 December 2025     Accepted: 12 January 2026     Published: 30 January 2026
Views:       Downloads:
Abstract

The present work deals with the isolation, purification and characterization of secondary metabolites of the fruits of Ziziphus mauritiana and the evaluation of their biological activity against Staphylococcus aureus. A plant from the Rhamnaceae family, widely used in the Cameroonian and Tchadian traditional pharmacopoeia for the treatment of various diseases such as food poisoning, pneumonia, urinary tract infections, and skin infections such as wounds and ulcers. Our investigations focused on the methanol/dichloromethane (MeOH/DCM, 1:1) extract of the fruits of Ziziphus mauritiana. Alkaloidal treatment was performed on this extract, and we obtained four (04) fractions: two non-alkaloid fractions, F1 (DCM), F2 (EtOAc), and two alkaloid fractions, F3 (DCM) and F4 (EtOAc). Using usual chromatographic methods (CC, CCM), we isolated from the alkaloidal fraction F3, two compounds 1 and 2, and four compounds 3, 4, 5, 6 from the non-alkaloid fraction F1, the hexane fraction. From these compounds, three (03) were fully characterized using spectroscopic methods 1H and 13C NMR (1 and 2 dimensions) and by comparison of their spectral data with those of the literature. These are: Sanjoinenine 1, betulinic acid 3, and epicatechin 4. The crude extract as well as fraction, and some isolated compounds were evaluated in vitro by the liquid microdilution method described by CLSI, against two strains of Staphylococcus aureus: S. aureus ATCC25923, S. aureus ATCC43300, and a Clinical isolate. The crude extract, fractions F1 and F4, were the most active fractions tested against the strain S. aureus ATCC 25923, with a MIC of 15.6, 62.5, and 15.6 µg/mL, respectively, while the other fractions (F2 and F3) showed moderate activity against the same strain. Fraction F2 is not active. For the S. aureus ATCC 43300, all the fractions have a weak activity, and for the clinical isolate, only ZSA shows a good activity with a MIC of 62.5 µg/mL, and the others show a moderate activity.

Published in American Journal of Applied Chemistry (Volume 14, Issue 1)
DOI 10.11648/j.ajac.20261401.11
Page(s) 1-10
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2026. Published by Science Publishing Group

Keywords

Ziziphus Mauritiana, Staphylococcus Aureus, Sanjoinenine 1, Betulinic Acid 3, Epicatechin 4

References
[1] Wierzchowska, K. (2023). The Occurrence of Methicillin-Resistant Staphylococcus Aureus (MRSA) Around the World and Antibiotic Therapy for Selected Infections Caused By MRSA. Postepy Mikrobiologii, 62(2), 101–111.
[2] Lee, A. S., Lee, A. S., de Lencastre, H., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. J. (2018). Methicillin-resistant Staphylococcus aureus. 4(1), 18033.
[3] Falagas, M. E., Karageorgopoulos, D. E., Leptidis, J., & Korbila, I. P. (2013). MRSA in Africa: filling the global map of antimicrobial resistance. PLOS ONE, 8(7).
[4] Eshetie S., Tarekegn F., Moges F., Amsalu A., Birhan W., Huruy K (2016). Methicillin resistant Staphylococcus aureus in Ethiopia: a meta-analysis. BMC Infection Disease 16: 689 694.
[5] Bérdy J., (2005). Bioactive microbial metabolites. Journa of Antibiotic 58: 1– 26.
[6] Lei Yang L., Yang C., Li C., Zhao Q., Liu L., Fang X., Ya Chen X (2016). Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants. Sciences Bull. 61: 3–17.
[7] Said A., Huefner A., Tabl E., & Fawzy G., (2006). Two new cyclic amino acids from the seeds and antiviral activity of methanolic extract of the roots of Zizyphus spina-christi. Paper presented at the 54th Annual Congress on Medicinal Plant Research. Planta Medica, 72, 222.
[8] Jaradat, N. (2005). Medical Plants Utilized in Palestinian Folk Medicine for Treatment of Diabetes Mellitus and Cardiac diseases.
[9] Saied, A. S., Gebauer, J., Hammer, K., & Buerkert, A. (2008). Ziziphus spina-christi (L.) Willd.: a multipurpose fruit tree. Genetic resources and crop evolution, 55(7), 929-937.
[10] Abalaka M. E., Daniyan S. Y., Mann A., (2010). Evaluation of the antimicrobial activities of two Ziziphus species (Ziziphus mauritiana L. and Ziziphus spina christi L.) on some microbialpathogens. African Journal of Pharmacy and Pharmacology, 4(4): 135-139.
[11] Harikrishnan, R., & Balasundaram, C. (2020). Potential of herbal extracts and bioactive compounds for human healthcare. In The Role of Phytoconstitutents in Health Care (pp. 3-158). Apple Academic Press.
[12] Irfanitha, I., Naid, T., & Nuryanti, S. (2024). Aktivitas Antibakteri Ekstrak Metanol Daun Bidara (Ziziphus mauritiana Lam) Terhadap Bakteri Uji Penyebab Luka Infeksi Dengan Metode Difusi Agar. 2(1), 182–192.
[13] Jiamboonsri, P., Pithayanukul, P., Bavovada, R., & Traidej Chomnawang, M. (2011). The Inhibitory Potential of Thai Mango Seed Kernel Extract against Methicillin-Resistant Staphylococcus Aureus. Molecules, 16(8), 6255–6270.
[14] Joray, M. B., González, M. L., Palacios, S. M., & Carpinella, M. C. (2011). Antibacterial activity of the plant-derived compounds 23-methyl-6-O-desmethylauricepyrone and (Z, Z)-5-(trideca-4, 7-dienyl) resorcinol and their synergy with antibiotics against methicillin-susceptible and -resistant Staphylococcus aureus. Journal of Agricultural and Food Chemistry, 59(21), 11534–11542.
[15] Mm, A., Am, M., Ia, U., Da, A., Joseph, I., Louis, H., & Amos, P. I. (2017). Phytochemical Screening and Antimicrobial Activity of the Pulp Extract and Fractions of Ziziphus mauritiana. Biochemistry & Analytical Biochemistry, 7(2), 1–6.
[16] Pájaro-González, Y., Oliveros-Díaz, A., Cabrera-Barraza, J., Fernández-Daza, E., Reyes, N., Montes-Guevara, O. A., Caro-Fuentes, D., Franco-Ospina, L. A., Quiñones-Fletcher, W., Quave, C. L., & Díaz-Castillo, F. (2022). Mammea B/BA Isolated From the Seeds of Mammea americana L. (Calophyllaceae) is a Potent Inhibitor of Methicillin-Resistant Staphylococcus aureus. Frontiers in Pharmacology, 13.
[17] Samsi, A. S., & Suriati, I. (2023). Uji Aktivitas Antibakter Formulasi Sediaan Salep Ekstrak Daun Bidara (Ziziphus mauritania) terhadap Bakteri Staphylococcus aureus. Indonesian Journal of Pharmaceutical Education, 3(2).
[18] Sorres, J., André, A., Van Elslande, E., Stien, D., & Eparvier, V. (2020). Potent and Non-Cytotoxic Antibacterial Compounds Against Methicillin-Resistant Staphylococcus aureus Isolated from Psiloxylon mauritianum, A Medicinal Plant from Reunion Island. Molecules, 25(16), 3565.
[19] Syafa’atulloh, M. Y., Setiawati, Y., & Retnowati, W. (2022). In Vitro Study of Antibacterial Activity of Bidara Leaf Extract (Ziziphus mauritiana) against Staphylococcus aureus and MRSA. International Journal of Research Publications, 113(1).
[20] Zamzam, M. Y., Rohadi, D., & Rizkyan, A. W. (2024). UJI AKTIVITAS ANTIBAKTERI EKSTRAK ETANOL TERPURI-FIKASI DAUN BIDARA ARAB (Ziziphus spina-christi L.) TERHADAP BAKTERI Staphylococcus aureus. Medimuh, 5(1), 15–26.
[21] AL-Salman, H. N., Ali, E. T., Almukhtar, O. A., & Jabir, M. S. (2020). 2-benzhydrylsulfinyl-N-hydroxyacetamide extracted from fig: A good therapeutic agent against Staphylococcus aureus. 2213, 020223.
[22] Abu-Zarga M., Salim S., AL-Aboudi A., Saleh A. M., Naheed S. and Atta-Ur-Rahman, (April 1995). New cyclopeptide alkaloids from Ziziphus lotus. Journal of Natural Products Vol. 58, No. 4: 504-511.
[23] Tuenter E., Exarchou V., Balde A., Cos P., Maes L., Aper S. and Pieters L., 2016. Cyclopeptide alkaloids from Hymenocardia acida. Journal of Natural Product 79(7): 1746- 1751.
[24] Han, B. H., & Boudjouk, P. (1982). Organic sonochemistry. Sonic acceleration of the Reformatsky reaction. The Journal of Organic Chemistry, 47(25), 5030-5032.
Cite This Article
  • APA Style

    Mahamat, A. A., Adannou, H. A., Heloua, H., Mbarga, P. E., Blandine, O. W., et al. (2026). Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana. American Journal of Applied Chemistry, 14(1), 1-10. https://doi.org/10.11648/j.ajac.20261401.11

    Copy | Download

    ACS Style

    Mahamat, A. A.; Adannou, H. A.; Heloua, H.; Mbarga, P. E.; Blandine, O. W., et al. Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana. Am. J. Appl. Chem. 2026, 14(1), 1-10. doi: 10.11648/j.ajac.20261401.11

    Copy | Download

    AMA Style

    Mahamat AA, Adannou HA, Heloua H, Mbarga PE, Blandine OW, et al. Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana. Am J Appl Chem. 2026;14(1):1-10. doi: 10.11648/j.ajac.20261401.11

    Copy | Download

  • @article{10.11648/j.ajac.20261401.11,
      author = {Aboubakar Ali Mahamat and Haroun Ali Adannou and Haroun Heloua and Paul Etoga Mbarga and Ouahouo Wache Blandine and Pierre Mkounga and Ephrem Augustin Nkengfack},
      title = {Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana},
      journal = {American Journal of Applied Chemistry},
      volume = {14},
      number = {1},
      pages = {1-10},
      doi = {10.11648/j.ajac.20261401.11},
      url = {https://doi.org/10.11648/j.ajac.20261401.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajac.20261401.11},
      abstract = {The present work deals with the isolation, purification and characterization of secondary metabolites of the fruits of Ziziphus mauritiana and the evaluation of their biological activity against Staphylococcus aureus. A plant from the Rhamnaceae family, widely used in the Cameroonian and Tchadian traditional pharmacopoeia for the treatment of various diseases such as food poisoning, pneumonia, urinary tract infections, and skin infections such as wounds and ulcers. Our investigations focused on the methanol/dichloromethane (MeOH/DCM, 1:1) extract of the fruits of Ziziphus mauritiana. Alkaloidal treatment was performed on this extract, and we obtained four (04) fractions: two non-alkaloid fractions, F1 (DCM), F2 (EtOAc), and two alkaloid fractions, F3 (DCM) and F4 (EtOAc). Using usual chromatographic methods (CC, CCM), we isolated from the alkaloidal fraction F3, two compounds 1 and 2, and four compounds 3, 4, 5, 6 from the non-alkaloid fraction F1, the hexane fraction. From these compounds, three (03) were fully characterized using spectroscopic methods 1H and 13C NMR (1 and 2 dimensions) and by comparison of their spectral data with those of the literature. These are: Sanjoinenine 1, betulinic acid 3, and epicatechin 4. The crude extract as well as fraction, and some isolated compounds were evaluated in vitro by the liquid microdilution method described by CLSI, against two strains of Staphylococcus aureus: S. aureus ATCC25923, S. aureus ATCC43300, and a Clinical isolate. The crude extract, fractions F1 and F4, were the most active fractions tested against the strain S. aureus ATCC 25923, with a MIC of 15.6, 62.5, and 15.6 µg/mL, respectively, while the other fractions (F2 and F3) showed moderate activity against the same strain. Fraction F2 is not active. For the S. aureus ATCC 43300, all the fractions have a weak activity, and for the clinical isolate, only ZSA shows a good activity with a MIC of 62.5 µg/mL, and the others show a moderate activity.},
     year = {2026}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Anti-Staphylococcus Aureus Guide Isolation of Compounds from the Fruits of Ziziphus Mauritiana
    AU  - Aboubakar Ali Mahamat
    AU  - Haroun Ali Adannou
    AU  - Haroun Heloua
    AU  - Paul Etoga Mbarga
    AU  - Ouahouo Wache Blandine
    AU  - Pierre Mkounga
    AU  - Ephrem Augustin Nkengfack
    Y1  - 2026/01/30
    PY  - 2026
    N1  - https://doi.org/10.11648/j.ajac.20261401.11
    DO  - 10.11648/j.ajac.20261401.11
    T2  - American Journal of Applied Chemistry
    JF  - American Journal of Applied Chemistry
    JO  - American Journal of Applied Chemistry
    SP  - 1
    EP  - 10
    PB  - Science Publishing Group
    SN  - 2330-8745
    UR  - https://doi.org/10.11648/j.ajac.20261401.11
    AB  - The present work deals with the isolation, purification and characterization of secondary metabolites of the fruits of Ziziphus mauritiana and the evaluation of their biological activity against Staphylococcus aureus. A plant from the Rhamnaceae family, widely used in the Cameroonian and Tchadian traditional pharmacopoeia for the treatment of various diseases such as food poisoning, pneumonia, urinary tract infections, and skin infections such as wounds and ulcers. Our investigations focused on the methanol/dichloromethane (MeOH/DCM, 1:1) extract of the fruits of Ziziphus mauritiana. Alkaloidal treatment was performed on this extract, and we obtained four (04) fractions: two non-alkaloid fractions, F1 (DCM), F2 (EtOAc), and two alkaloid fractions, F3 (DCM) and F4 (EtOAc). Using usual chromatographic methods (CC, CCM), we isolated from the alkaloidal fraction F3, two compounds 1 and 2, and four compounds 3, 4, 5, 6 from the non-alkaloid fraction F1, the hexane fraction. From these compounds, three (03) were fully characterized using spectroscopic methods 1H and 13C NMR (1 and 2 dimensions) and by comparison of their spectral data with those of the literature. These are: Sanjoinenine 1, betulinic acid 3, and epicatechin 4. The crude extract as well as fraction, and some isolated compounds were evaluated in vitro by the liquid microdilution method described by CLSI, against two strains of Staphylococcus aureus: S. aureus ATCC25923, S. aureus ATCC43300, and a Clinical isolate. The crude extract, fractions F1 and F4, were the most active fractions tested against the strain S. aureus ATCC 25923, with a MIC of 15.6, 62.5, and 15.6 µg/mL, respectively, while the other fractions (F2 and F3) showed moderate activity against the same strain. Fraction F2 is not active. For the S. aureus ATCC 43300, all the fractions have a weak activity, and for the clinical isolate, only ZSA shows a good activity with a MIC of 62.5 µg/mL, and the others show a moderate activity.
    VL  - 14
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Exact and Applied Sciences, Higher Teacher Training College of N'Djamena, N'djamena, Chad

  • Department of Chemistry, University of N'Djamena, N'Djamena, Chad

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Department of Organic Chemistry, University of Yaoundé I, Yaoundé, Cameroon

  • Sections